PROVETOP

Rat ALK-7/Activin RIC Protein

Catalog No: ALK7-RF001

Species
Rat
Expression System
HEK293
Tag
an hFc (IgG1)
Activity
Activity verified

Product overview

Recombinant Rat ALK-7/Activin RIC Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Leu26-Glu113 (UniProt accession: P70539).

Product Details

Molecular Aliases
ACTR-IC; ACVR1C; ALK7; Activin R1C;
Protein Length
Leu26-Glu113
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 35.46 kDa. Due to glycosylation, the protein migrates to 48-68 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE > 90% as determined by HPLC
Endotoxin
Less than 0.1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in 20mM Tris, 150mM NaCl (pH 7.5). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
ALK7-RF001 Bis-Tris-PAGE-white result

Rat ALK-7 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC
ALK7-RF001 SEC-HPLC result

The purity of Rat ALK-7 is greater than 90% as determined by SEC-HPLC.

ELISA
ALK7-RF001 ELISA result

Immobilized Rat ALK-7, hFc Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Biotinylated Anti-ALK-7 Antibody, hFc Tag with the EC50 of 7.8ng/ml determined by ELISA. (QC Test)

Background

Arterial stiffness is an important feature of diabetic macrovascular complications. Activin receptor-like kinase 7 (ALK7), a member of type I transforming growth factor-β (TGF-β) receptors, is correlated with pathogenic risks of type 2 diabetes mellitus and cardiovascular diseases and may be involved in cardiovascular remodeling.

References

  1. Li WB, Zhao J, Liu L, Wang ZH, Han L, Zhong M, Zhang Y, Zhang W, Tang MX. Silencing of activin receptor-like kinase 7 alleviates aortic stiffness in type 2 diabetic rats. Acta Diabetol. 2015 Aug;52(4):717-26. doi: 10.1007/s00592-014-0706-8. Epub 2015 Jan 11. PMID: 25577243.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support